Does apocrine differentiation/AR positivity alter your radiation recommendations for triple negative breast cancer?  

Chemotherapy is often de-escalated and omitted in this setting. Would you also consider de-escalating radiation and treating like more favorable histologies, such as observing older patients after lumpectomy, omitting RNI, boosts, etc?



Answer from: Radiation Oncologist at Community Practice